The Impact of Isoquercetin and Aspirin on Platelet Function

Trial Profile

The Impact of Isoquercetin and Aspirin on Platelet Function

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 01 Dec 2016

At a glance

  • Drugs Quercetin (Primary) ; Aspirin
  • Indications Cardiovascular disorders
  • Focus Therapeutic Use
  • Acronyms QUAP
  • Most Recent Events

    • 28 Nov 2016 Planned End Date changed from 1 May 2017 to 1 Oct 2016.
    • 28 Nov 2016 Planned primary completion date changed from 1 May 2017 to 1 Oct 2016.
    • 28 Nov 2016 Status changed from not yet recruiting to withdrawn prior to enrolment.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top